MarketBeat on MSN
Is Abbott's January pullback a good time to buy?
Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven ...
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed ...
PHILADELPHIA -- Abbott Nutrition is recalling one lot of Similac PM 60/40 powdered infant formula due to another report of a dangerous bacterial infection. The Centers for Disease Control and ...
Abbott's fourth quarter revenue missed expectations in its devices, diagnostics and nutrition segments, while staying in line for its established pharmaceutical business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results